Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc
Bullboard Posts
User Avatar Image
(3)
•••
Post by daydream1on May 31, 2011 1:38pm
347 Views
Post# 18650685

Tic, toc, tic, toc...

Tic, toc, tic, toc...

Today is that last day of the 1st half of 2011. Shouldn’t NRI be announcing WF10 results any time now? Or will they just once again renege on their commitment to report WF10 final reslut by the end of th2011 1st quarter? Pennsaid sales or ZARS deal is not the story here. It is what can WF10 bring to NRI. Immunological research has nothing to do with NRI’s present and future business direction. If WF10 has significant use why does NRI not sale it. This will lower their research expenses and bring in cash. That is what investors are waiting... WF10 trails results.

Goodluck

D.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities